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ABSTRACT (300 words unstructured) 
 
Variations in access to health care are known to contribute to differences in life 
expectancy, morbidity and health-related quality-of-life across population subgroups.  
We undertook a scoping review to identify what is known about in-country variations 
in access to services for adults with multiple sclerosis and to identify gaps in the 
literature to inform future research and national policies. We searched MEDLINE, 
CINAHL, EMBASE, PSYCHINFO, SocINDEX and Social Science Abstracts from 
inception to end of December 2016 for quantitative studies which had investigated 
differences in access to prevention services, healthcare services, treatments and 
social care between inequality groups, defined using the PROGRESS-PLUS 
framework. A total of 4959 unique abstracts yielded 36 papers which met our 
eligibility criteria.  Only 3 studies were cohort studies and only 4 were population-
based; most were from the United States (n=27). There were 6 studies on access to 
MS focused care and 6 on access to Disease Modifying treatments. There were 3 
studies on access to prevention/lifestyle programmes and none on access to welfare 
services or information support. There were no papers examining inequalities in 
access for ‘vulnerable’ groups, such as, those with learning disability.  In the 
available studies, there was evidence of inequalities in access to services with a 
trend for worse access among men, older age groups, those from lower socio-
economic groups or the least educated, non-caucasians, those with mental health 
problems and those from rural areas. In the studies on access to disease modifying 
treatments, older age and lower socioeconomic status were consistently associated 
with a lower rate of uptake, while race and gender were not. Inequalities or 
disparities in access to all levels of services and treatments will need to be 
addressed through a strategic research agenda with an emphasis on population-
based studies and development and evaluation of interventions to reduce inequality.   
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INTRODUCTION 1 
 2 
Variations in access to health care are known to contribute to differences in life 3 
expectancy, morbidity and health-related quality-of-life across population subgroups 4 
[1-4].  When these variations are avoidable they contribute to inequalities or 5 
disparities in health experience [5] and have led to international and national 6 
strategies to reduce gaps in service provision, particularly, when there is evidence of 7 
lack of access to proven effective interventions or clinical variations in care [6-8].  8 
The Multiple Sclerosis Atlas has demonstrated gross international differences in 9 
mortality in multiple sclerosis and access to disease modifying treatments [9]. 10 
However, studies also suggest variations within countries, with some evidence that 11 
place of residence and sociodemographic characteristics (e.g., age, gender and 12 
ethnicity) have an influence on patient outcome [10-12].  There is also concern about 13 
variations in access to disease modifying treatments for some patient subgroups, 14 
which might be, in part, secondary to how health services are organised [13,14].  In 15 
chronic conditions like multiple sclerosis (MS), it is also important to consider 16 
inequalities in access to services and treatments which reduce morbidity across the 17 
care pathway, from secondary prevention to rehabilitation and social care [15]. The 18 
complex needs of many patients with MS require the input of many other services, 19 
such as physiotherapy, occupational therapy and mental health services, as these 20 
treatments/therapies have been shown to reduce morbidity in MS [16-18].  21 
Independence and participation may be maintained through social support, personal 22 
support and housing adaptations, and the employment consequences of an MS 23 
diagnosis through vocational rehabilitation [19].  More recently, there has been a 24 
greater focus on improving well-being through promoting healthy lifestyles among 25 
adults with multiple sclerosis, because of evidence that increased physical activity 26 
helps to maintain physical functioning and improve mental health in MS patients [20] 27 
and because smoking may raise the risk of disease progression [21].  Therefore, 28 
variations in access to lifestyle and prevention programmes is also important. 29 
We undertook a scoping review of the literature to identify what is known about in-30 
country variations in access to services for adults with MS and to identify gaps in the 31 
literature to inform future research and national policies.  A scoping review uses 32 
systematic methods to identify the literature but addresses a broader question than a 33 
systematic review. As  such, it is less concerned with the reporting quality of the 34 
papers or meta-analysis. In this scoping review, we identified and reviewed studies 35 
which used a quantitative methodology to investigate intra-national (in-country) 36 
variations in access across the care pathway and health systems of different 37 
inequality groups among populations of adult MS patients.  38 
 39 
METHODS 40 
Although this study was not focused on the effectiveness of interventions to reduce 41 
inequity, we used the Joanna Briggs Institute guidance on scoping reviews [22] and 42 
the Cochrane and Campbell Equity methods group checklist [23] to guide the 43 
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development of the study protocol, study implementation and presentation of 1 
findings. This study was funded by Salford Royal NHS Hospitals Foundation Trust. 2 
 3 
Definition of exposures (Inequality groups) 4 
We used the PROGRESS-PLUS framework for determining inequality groups in this 5 
review [24]. These were used to guide terms in the search strategy and to stratify 6 
studies in the analysis. In this framework the PROGRESS inequality groups (place of 7 
residence, race/ethnicity/culture/language, occupation/employment status, 8 
gender/sex, religion, education, socio-economic status, and social capital) were 9 
supplemented by ‘PLUS’ inequality groups related to personal characteristics 10 
pertinent to MS patients: age, disability (physical +/or cognitive), disease type, 11 
mental health conditions, and other ‘vulnerable groups’, e.g., learning difficulties, 12 
travelers, migrants.  The ‘PLUS’ groups were chosen based on the potential for 13 
barriers to access of services and/or treatments following discussion within the 14 
review team, which consisted of clinicians and public health professionals. When 15 
considering social capital, we took a broad and inclusive approach to its definition 16 
and included all aspects of social networks and social cohesion under this umbrella 17 
term [25]. We also included a broad range of indicators of socioeconomic status, e.g, 18 
deprivation indices, income.  19 
 20 
Definition of outcomes (programmes/services/treatments)  21 
À priori, we broadly categorised the programmes/services/treatments and, post-hoc, 22 
agreed subcategories for presentation when studies were found. The categories 23 
(and subcategories) included:  prevention programmes (subcategories: primary and 24 
secondary prevention), diagnostic investigations, medical care (subcategories: 25 
medication general, disease modifying treatments, general health care, neurology 26 
services, MS specific services, health provider systems e.g., health maintenance 27 
organisation), mental health services, rehabilitation services, social and welfare 28 
services (personal support, housing, assisted devices or assisted living) and 29 
information support. 30 
 31 
Eligibility criteria 32 
We included studies with a quantitative research design from any country and 33 
healthcare setting if they compared inequality MS groups as to uptake of, or access 34 
to programmes, services or treatments across the prevention/care/support pathway. 35 
Participants could have any type or stage of MS and be at any time following 36 
diagnosis. As the focus was on adult MS patients, we excluded any study in which 37 
more than 5% of the population was under 16 years of age. We also excluded 38 
studies comparing MS patients with the general population or with other patient 39 
groups, studies investigating uptake of alternative or complementary therapies, those 40 
that focused on uptake of lifestyles rather than the services which promote lifestyle 41 
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modification, those investigating DMT adherence rather than prescription and studies 1 
where the outcome was perceived or reported need, rather than comparative need.   2 
 3 
Search strategy 4 
We searched MEDLINE, CINAHL, EMBASE, PSYCHINFO, SocINDEX and Social 5 
Science Abstracts from inception to end of December 2016 using the key terms for 6 
multiple sclerosis as recommended by the Cochrane Multiple Sclerosis and Rare 7 
Diseases Review Group [26] and search terms for inequalities/disparities and the 8 
inequality groups, adapted as appropriate for the different databases. The search 9 
was limited to English Language articles. The full search strategy for MEDLINE 10 
(EBSCO) is included in supplementary materials (supplementary table 1). The titles 11 
and abstracts were screened by teams of two authors independently and any 12 
conflicts resolved by a third reviewer.  13 
 14 
Data retrieval, extraction and analysis 15 
Full text papers for all potentially eligible studies identified by the search, and when 16 
there was insufficient detail in the title/abstract to determine eligibility, were retrieved 17 
and screened for inclusion by two researchers, with a third reviewer resolving any 18 
conflicts.  Data was extracted for each of the identified studies using a specially 19 
designed proforma.  Data was extracted on the study design, country and setting, 20 
definition of MS, sample size, population characteristics, setting, data source, 21 
exposures (PROGRESS-PLUS categories), outcomes (uptake/access) and key 22 
findings for each exposure/outcome relationship reported. Data was extracted by 23 
one researcher and all data was checked by a second researcher, with conflicts 24 
being resolved by discussion. The dataset was synthesised narratively after 25 
discussion with the full review team. 26 
 27 
RESULTS 28 
A total of 4959 unique abstracts were identified from the databases following 29 
automatic removal of duplicates. This yielded 157 full text papers for eligibility 30 
screening and a further paper was identified from other sources [15].  A total of 36 31 
papers were deemed eligible for further analysis [15, 27-61]. Reasons for exclusion 32 
for the other 122 papers included: a lack of focus on inequality (n = 23); non-eligible 33 
study design (n= 26); non-eligible study population (n=18); exposures inconsistent 34 
with the PROGRESS-PLUS framework (n=27) or lack of data on access to a service 35 
or treatment (n=28).  Figure 1 shows the flow diagram of search results. 36 
Figure 1: Flow chart of search  37 
 38 
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 1 
 2 
The full characteristics of the 36 studies is shown in supplementary table 2. Only 3 3 
studies were cohort studies [28, 47, 55] and only 4 were population-based [46, 47, 4 
52, 58]. The data source for 12 of the 36 was in full, or in part, from the members of 5 
National Multiple Sclerosis Society [32, 33, 36, 37, 41, 42, 43, 48, 49, 53, 54, 56] and 6 
for 4 studies the North American Research Committee on Multiple Sclerosis 7 
(NARCOMS) register [30, 44, 45, 56]. There were also 4 studies which used the 8 
Minimum Data Set (MDS) for Medicare/Medicaid certified Nursing Homes (two of 9 
which used the same sample) [29, 31, 34, 35] and 3 which drew on a single survey 10 
(‘’Aging With MS: Unmet Needs in the Great Lakes Region" survey) [38, 39, 40]. The 11 
Records after duplicates 
removed  
n=4959 
Records identified through database searching 
(n=5113) 
Records identified from 
other sources (n= 1) 
Papers assessed for focus on 
health inequality and access 
to services 
n=158 
Papers excluded n=122 
-no inequality focus: 23 
-study design: 26 
-not population of interest: 18 
-not exposure of interest: 27 
-not outcome of interest: 28 
Studies included for data 
extraction  
n=36 
Records excluded on title and 
abstracts (n= 4802) 
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studies were published between 2000 and 2016 with 10 studies published since 1 
2010 [30, 38, 39, 46, 47, 51, 53, 55, 56, 61]. Most of the studies were undertaken in 2 
the US (n=27) and all studies were undertaken in North America or Western Europe.   3 
Figure 2 and table 1 show the numbers of studies focusing on the different access 4 
outcome categories and subcategories. There were 10 unique studies on access to 5 
medical services, of which, six studies were on access to MS focused care. Eight 6 
unique studies focused on access to medications, of which, 6 were on access to 7 
Disease Modifying treatments. A similar number of papers were on access to mental 8 
health services (n=7), rehabilitation (n=8), and social support/care (n=7). There were 9 
a few studies on diagnostic services (n=2), access to prevention/lifestyle 10 
programmes (n=3) and on housing adaptions or aids (n=4), but no studies on access 11 
to welfare services or information support.  All three studies about inequalities in 12 
access to health provider systems were from the United States.  13 
Figure 2: Number of papers by access subcategory 14 
 15 
 16 
 17 
Table 1 summary of findings here (see separate file) 18 
 19 
The effect of gender was examined across all access subcategories for which there 20 
were studies, and disability and socioeconomic status across all but one. Gender 21 
(n=25), age (n=21) and disability (n=18) were most frequently included as exposure 22 
factors.  In contrast, mental health status (n=9), occupation, i.e., employment status, 23 
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(n=9), and disease type (n=7) were less frequently examined. Given the setting of 1 
most of the papers, the 15 studies about race mainly focused on differences 2 
between Caucasian, African American and Hispanic populations.  Those on place 3 
(n= 13) compared urban and rural populations and all the papers categorised under 4 
social capital (n= 14) were on marital status or living arrangements. There were no 5 
papers examining ‘vulnerable’ groups or religion as factors affecting access to 6 
services/treatments.   7 
The findings for each access category is shown in table 1. There was evidence of 8 
inequalities in access to services, but the relationship was not consistent across 9 
access subcategories. Broadly, there was a trend for worse access among men, 10 
older age groups, those from lower socio-economic groups or the least educated, 11 
non-caucasians, those with mental health problems and those from rural areas. 12 
However these findings were not universal, for example, women were less likely than 13 
men to see a urologist or have a powered wheelchair, and younger patients were 14 
less likely to be in receipt of personal assistance.  In the studies on access to 15 
disease modifying treatments, older age and lower socioeconomic status were 16 
consistently associated with a lower rate of uptake, while race and gender were not.  17 
The relationship between severity of disability and levels of access across the care 18 
pathway was complex; with evidence of worse access to primary prevention and 19 
neurology services, no evidence of access issues to MS specific care and better 20 
access to rehabilitation, social care and assisted living. 21 
 22 
DISCUSSION 23 
In the limited number of studies identified, the findings of this scoping review support 24 
the existence of inequality, or disparity, in access to services among MS 25 
subpopulations within countries. The subpopulations experiencing inequality are 26 
similar to those experiencing access or uptake issues in other conditions.  For 27 
example, in cancer screening men, minority ethnic groups and those from more 28 
deprived areas have lower rates of bowel screening [62]; older adults are less likely 29 
to receive proven effective treatments [63]; and rurality has been associated with 30 
lower access to specialist services [64]. However, this review also suggests that 31 
interpreting variations in access rates as an inequality or disparity is complex.  There 32 
was some evidence that inequalities may be context specific. For example, women 33 
rather than men were less likely to be referred to a urologist. Urinary symptoms are 34 
very common in multiple sclerosis, but one study suggested that only two thirds of 35 
patients are asked about these symptoms by their clinician [65]. Gender disparity in 36 
referral to urologists has also been observed in general populations with haematuria 37 
and voiding difficulties, with women less likely to be referred and more likely to be 38 
treated for urinary tract infections [66,67].  Depending on the population subgroup, a 39 
higher or a lower uptake rate might be interpreted as an inequality for the same 40 
service.  For example, in the study by Marrie [46], access to ICU was lower among 41 
those living in rural areas, which might suggest that because of the distance from 42 
specialist services those in rural areas could not obtain necessary management.  43 
However, access to intensive care units (ICU) was higher among men and older 44 
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patients. This could be interpreted as women and younger patients being less likely 1 
to benefit from necessary care; but equally could be interpreted that men and older 2 
patients are less likely to receive appropriate care to prevent overwhelming 3 
infections. Similarly, a lower rate of access to lifestyle interventions among those 4 
who are more disabled may be an inequality if they can benefit from these services; 5 
whereas a lower rate of access to home adaptations among those who are less 6 
disabled may not be an inequality, if they do not need such aids. These examples 7 
highlight the need for research to understand the reasons for differences between 8 
population subgroups: whilst some of these are likely to be similar to those 9 
experienced by adults with other co-morbidities [68], some are likely to be disease 10 
specific. Such research will also facilitate the development of strategies to reduce 11 
important variations.  12 
Further difficulties in interpretation were introduced by the study designs.  Few 13 
studies used a cohort design and therefore in most studies both exposure and 14 
outcome were measured at the same time.  While this may not affect some 15 
exposures (such as gender), the interpretation of the direction of effect can be more 16 
problematic for exposures such as mental health or disability.  So for example, in the 17 
study by Buchanan et al, nursing residents who were depressed were less likely to 18 
have occupational therapy (OT) [29].  As this was a cross-sectional study, it was 19 
unclear whether they had less OT because they were depressed, or not having OT 20 
made them depressed.  Furthermore, there were other concerns about the quality of 21 
these studies: not all studies undertook a multivariate analysis to assess whether the 22 
exposures were independent risk factors.  Few studies were population-based and 23 
many relied on members of MS societies: these groups might be less likely to 24 
include those from lower socio-economic groups, the less educated and minority 25 
groups [42, 43]. Finally, the generalisability of the findings may be limited because 26 
the majority were undertaken in US and all within western developed countries. Even 27 
then, the organisation and funding of health and social care systems in the US and 28 
the geography and racial breakdown are substantially different to that of, for 29 
example, the United Kingdom, where only 3 studies have been undertaken [15, 51, 30 
52]. 31 
There were a relatively high number of studies investigating access to disease 32 
modifying treatments. This is perhaps unsurprising, given the controversies around 33 
funding of these effective but expensive drugs; particularly when they first came to 34 
market [51]. More recent studies suggest that in addition to concerns about 35 
socioeconomic disadvantage having an impact on access to first line Disease 36 
Modifying Treatments (DMTs), there still remain concern about access of patients 37 
from lower socioeconomic groups to second line treatments [69]. There were very 38 
few studies about prevention programmes, which might reflect the relative recency of 39 
the interest in lifestyle interventions to promote well-being in MS populations. 40 
Nevertheless, promotion of physical activity, safe alcohol consumption and smoking 41 
cessation are incorporated into some national guidelines for MS care [70], and 42 
further work on access to these interventions overall and across inequality groups is 43 
warranted.  It is perhaps more surprising that there were no studies on access to 44 
vocational rehabilitation services, and few on the impact of unemployment on access 45 
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to services, given the considerable research on the difficulties encountered by adults 1 
with MS within the workplace and the detrimental impact of unemployment on their 2 
well-being [71, 72].  We also found no studies about access to informational support. 3 
There is increasing interest in developing self-management programmes including 4 
digital technology for patients.  While such programmes are important to promote 5 
well-being and patient engagement [13], there is the potential for introducing further 6 
health inequalities, as access to and use of the internet or mobile devices differs 7 
across socioeconomic and racial groups [73].                 8 
As well as the difficulties in interpretation, there were other limitations to our scoping 9 
review.  Because of resource limitations, only studies in the English language were 10 
included. This may in part account for the observation that there were relatively few 11 
countries included among the eligible studies.  We specifically excluded studies 12 
which focused only on perceived or expressed needs, as these are subjective. 13 
Studies reporting objectively measured needs were included, but perceived or 14 
expressed needs may under represent genuine inequalities as they may represent 15 
wants, although studies have shown that these can vary across inequality group [74]. 16 
We did not include qualitative studies as the objective was to compare across 17 
inequality groups, but these types of studies would give greater depth of 18 
understanding of why inequalities exist. Finally, the concluding step in Arksey and 19 
O’Malley’s original structure for scoping reviews includes a discussion with 20 
stakeholders of the findings [75].  This has not been formally undertaken with 21 
external stakeholders, but was addressed internally by the review team which 22 
included both researchers and clinicians. A recent scoping review on the conduct 23 
and reporting of scoping reviews suggests relatively few published scoping reviews 24 
undertake this step [76].  25 
 26 
CONCLUSION 27 
This scoping review was essential to benchmark the current evidence base and to 28 
demonstrate the paucity of published studies to date for this population. It has 29 
identified that inequalities exist throughout the prevention, care and support pathway 30 
for adults with MS, but the interpretation of these findings are limited by the lack of 31 
consistency between studies and across different types of care or support.  In part, 32 
this may be because inequality is likely to be context specific and, in part, because of 33 
the limitations of the study design. There were also some specific research gaps 34 
identified, particularly in relation to prevention, vocational support and patient 35 
information and within inequality groups, learning disabilities and other ‘vulnerable’ 36 
groups. Inequalities or disparities in access to all levels of services and treatments 37 
will need to be addressed through a strategic research agenda. Further research to 38 
explore these areas requires large-scale population-based databases to ensure that 39 
participants are representative. Longitudinal studies also need to be responsive to 40 
changes in evidence about the management and treatment of MS.  Further research 41 
is needed into understanding the reasons for differences in access to develop 42 
strategies to address any inequality. The findings of this scoping review will help to 43 
inform the prioritisation of future research for this population internationally.  44 
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